1
Study to Assess Safety, Reactogenicity and Immunogenicity of the repRNA(QTP104) Vaccine Against SARS-CoV-2(COVID-19)
Condition(s):COVID-19; SARS-CoV-2Last Updated:May 25, 2023Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):COVID-19; SARS-CoV-2Last Updated:May 25, 2023Active, not recruiting
Condition(s):COVID-19Last Updated:January 26, 2023Completed
Condition(s):SARS-CoV-2Last Updated:April 4, 2022Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.